Avedro, Inc. Announces The Start Of Two New US FDA Trials for Accelerated Cross-linking
WALTHAM, Mass.--(BUSINESS WIRE)--Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
Help employers find you! Check out all the jobs and post your resume.